Clinical Trial Update: Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60 [Phase 3]

View source ↗

Summary

APhase 3 trial evaluating DAC plus HAAG regimen for newly diagnosed AML patients over 60 years old; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• DAC
• HAAG regimen

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Myeloid Leukemia, Induction Chemotherapy | Phase 3 | Status: UNKNOWN